Tron Logo
Trade on HitBTC
Like this video

Whitepaper VR MED

The First VR Solution In MedTech

VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system.This equipment covers a large part of the clinic’s needs with VR technology.Today, the VR headset is capable of replacing 40% of all instrument functionality ophthalmology room, having a cost of 6 times less than the cost equipment "Golden Standard". Development of new directions of diagnostics and treatment of patients is conducted.The technology is patented. VRMD tokens will become an internal currency of the platform, allowing users to get software to extend the functionality of the gadget and support new developments on the platform.

3.2
2 1 expert rating
Benchy 2.7
KYC
Experts
5.0
5.0
4.0
Review: coming soon PRO
Ended
Token
VRMD
Type
Price in ICO
0.2500 USD
Country
Whitelist/KYC
KYC & Whitelist
preICO start
19th Mar 2018
preICO end
15th Apr 2018
ICO start
7th Jun 2018
ICO end
5th Jul 2018
Visit ICO website
Report

Whitepaper

Missing whitepaper? Let us know.

Add to bookmarks
ICO KYC Report
Not conducted yet
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.5

Bamboo (Wellness)

BAMBOO aims to provide mankind with free* and borderless insurance through blockchain, ...

40 days 17 hours left
4.4

Worldopo

Become a Cryptolord in the the world’s first mobile game that combine Augmented Reali...

10 days 17 hours left
3.7

MADANA

MADANA is a platform for data analysis that uses Blockchain technology allowing partici...

4.1

HighVibe.Network

HighVibe.Network is a blockchain-based ecosystem designed to elevate human consciousnes...

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it